Bharat Biotech sues BHU researchers over Covaxin study
Thursday, 12 September 2024
Bharat Biotech has taken legal action against 11 BHU researchers and the journal Drug Safety over a study on Covaxin's side effects. Alleging defamation, Bharat Biotech seeks a permanent injunction and Rs 5 crore in damages. The researchers argue that the lawsuit aims to suppress criticism and hinder academic freedom.
Bharat Biotech has taken legal action against 11 BHU researchers and the journal Drug Safety over a study on Covaxin's side effects. Alleging defamation, Bharat Biotech seeks a permanent injunction and Rs 5 crore in damages. The researchers argue that the lawsuit aims to suppress criticism and hinder academic freedom.
|
||||
|
||||
You Might Like |